期刊文献+

从化地区复杂性肾结石晶体成分分析 被引量:3

Analysis of the crystalline composition of renal complex calcium calculus in Conghua
下载PDF
导出
摘要 目的:总结从化地区复杂性肾结石晶体化学成份特点,为预防其复发提供依据。方法:检测从化地区95例复杂性肾结石患者的结石晶体的化学成份,同时分析患者的相关临床资料。结果:本组95例复杂性肾结石患者中,结石晶体为混合成份91例(95.8%),其中草酸钙+磷酸钙47例(49.5%)、草酸钙+尿酸7例(7.4%)、草酸钙+磷酸钙+尿酸9例(9.5%)、草酸钙+磷酸钙+磷酸镁铵25例(26.3%)、草酸钙+磷酸钙+胱氨酸3例(3.2%);结石晶体为草酸钙成份4例(4.2%)。结论:从化地区复杂性肾结石以混合成份为主,应加强病因诊断并采用针对多种病因的积极的复发预防性治疗。 Objective:To summarize the characteristics of crystalline composition of renal complex calcium calculus in Conghua, and to provide evidences for prevention of its recurrence. Methods: 95 patients with renal complex calcium calculus were detected their crystalline composition and analyzed their clinical data. Results: Of 95 patients with renal complex calcium calculus, 91 patients (95.8%) were found with mixed calculus, including calcium oxalate ~ calcium phosphate ( n = 47,49.5 % ), calcium oxalate + Uric Acid ( n = 7,7.4% ), calcium oxalate + calcium phosphate + Uric Acid ( n = 9, 9.5 % ) , calcium oxalate + calcium phosphate + infection stone ( n = 25,26.3% ) , oxalate + calcium phosphate + cystine( n = 3, 3.2% ). Conclusion : The renal complex calcium calculus was mainly mixed calculus in Conghua. The diagnosis on factors should be enhanced so as to perform the active treatment aimed at various factors for prevention of recurrence.
出处 《广州医学院学报》 2012年第4期61-62,共2页 Academic Journal of Guangzhou Medical College
基金 卫生部卫生行业科研专项项目(201002010) 广州市科技计划项目(2009J1-C371-2)
关键词 复杂性肾结石 结石成份 混合成分 renal complex calcium calculus stone composition mixed calculus
  • 相关文献

参考文献10

  • 1Tiselius HG, Ackermann D, Alken P, et al. Guidelines on urolithiasis [ J ]. Eur Urol, 2001,40 (4) :362-371.
  • 2Rassweiler JJ, Renner C, Eisenberger F. The management of complex renal stones[J]. B JU Int,2000,86(8) :919-928.
  • 3Meretyk S, Gofrit ON, Gafni O, et al. Complete staghorn calculi : random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy [ J ]. J Urol, 1997,157 (3) :780-786.
  • 4David S. Reconsideration of the 1988 NIH consensus statement on prevention and treatment of kidney stones : Are the recommendations out of date [ J ]. Rev Urol, 2002,4 (2) :53-60.
  • 5Dretler SP. Ureteral stone disease. Options for management [ J]. Urol Clin North Am, 1990,17 ( 1 ) :217-230.
  • 6Bushinsky DA. Nephrolithiasis [ J ]. J Am Soc Nephrol, 1998,9 (5) :917-924.
  • 7Tiselius HG, Larsson L. Calcium phosphate:an important crystal phase in patients with recurrent calcium stone formation[ J]. Urol Res, 1993,21 (3) : 175-180.
  • 8Deganello S, Chou C. The uric acid-whewellite association in human kidney stones [ J]. Scan Electron Microsc, 1984, 22(Pt 2) :927-933.
  • 9Pak CY, Holt K, Zerwekh JE. Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation [ J]. Invest Urol, 1979, 17 ( 2 ) : 138-140.
  • 10Du Toit PJ, van Aswegen CH, Steyn PL, et al. Effects of bacteria involved with the .pathogenesis of infection- induced urolithiasis on the urokinase and sialidase (neuraminidase) activity [ J ]. Urol Res, 1992,20 ( 6 ) : 393 -397.

同被引文献16

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部